Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection

March 2015

Author(s): Agarwal K, Fung SK, Nguyen TT, Cheng W, Sicard E, Ryder SD, et al

J Hepatol. 2015 Mar;62(3):533-40. PubMed PMID: WOS:000349855400008. English.

NIHR Acknowledged: Yes